• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FLEXIMA APDL; TUBE, DRAINAGE, SUPRAPUBIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FLEXIMA APDL; TUBE, DRAINAGE, SUPRAPUBIC Back to Search Results
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/01/2022
Event Type  malfunction  
Event Description
It was reported via literature article that stent migration was encountered in one patient.After successful bile duct stones removal, an endoscopically retrievable plastic biliary stent was placed into the common bile duct (cbd).To reduce the costs, a novel technique was applied where they derived a retrievable internal plastic biliary stent from a pigtail internal-external drainage catheter.A 12f internal-external biliary drainage catheter (flexima; boston scientific, usa) was cut into two pieces at the site of the proximal radiopaque marker with a scalpel blade.The distal part was removed over the metal introducer and a polypropylene suture was applied to its cut margin before replacing it back onto the introducer.The proximal portion functioned as a pusher while the catheter was passed through the papilla over the guidewire.The proximal portion was then retrieved and the distal portion remained in the cbd serving as a stent while the suture was fixed to the skin to prevent stent migration.Three months after the procedure, the plastic biliary stent was withdrawn endoscopically.In one patient (3.4%), the plastic biliary stent migrated into the cbd, which was then expelled into the duodenum with a 5f diagnostic catheter percutaneously.
 
Manufacturer Narrative
B3: date of event estimated using the date the journal article was published.Gungoren, f.Z., erol, c., seker, m.Et al.(2022).The efficacy of percutaneous treatment methods in bile duct stones.Indian j surg.Https://doi.Org/10.1007/s12262-022-03610-1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLEXIMA APDL
Type of Device
TUBE, DRAINAGE, SUPRAPUBIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC DE COSTA RICA S.R.L.
2546 calle primera
alajuela
CS  
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key16877375
MDR Text Key314725450
Report Number2124215-2023-21977
Device Sequence Number1
Product Code FFA
Combination Product (y/n)N
Reporter Country CodeTU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 05/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/05/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/24/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-